Stage 2018:

Indolo[2,3-c]quinoline and indolo[3,2- d]benzazepine derivatives

Specific aims:
-> Synthesis of frameworks C and D based on reported synthetic procedures
-> Synthesis of modified indolo[2,3-c]quinolines and new indolo[3,2- d]benzazepines containing metal-binding sites
-> Purification and characterization of the obtained compounds

Deliverables: Stage 2018: At least four well characterized proligands; Scientific Report;

Scientific Report - Stage 1 (2018) – Indolo[2,3-c]quinoline and indolo[3,2-d]benzazepine derivatives containing metal-binding sites

Objective 1.Preparation of indoloquinoline and indolobenzazepine derivatives
Activity 1.1. Synthesis of indolo[2,3-c]quinoline and indolo[3,2-d]benzazepine frameworks based on reported synthetic procedures
Activity 1.2. Synthesis of modified indolo[2,3-c]quinolines and new indolo[3,2-d]benzazepines containing metal-binding sites
Activity 1.3.Purification and characterization of the obtained compounds
 
Expected results:

• At least four proligands full characterized - achieved objective
• Scientific Report –achieved objective

Stage Results:

• At least four proligands full characterized - achieved objective

In this stage the following activities have been performed:

All the objectives of this project stage, 2018, were met as planned achievement!